Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Lorazepam Contraindications and Precautions

Critical Clinical Situations Requiring Extreme Caution

  • Baseline respiratory insufficiency significantly increases risk of benzodiazepine-induced respiratory depression, particularly when lorazepam is combined with opioids or other CNS depressants 1, 2, 3
  • Respiratory depression is dose-dependent and more pronounced with concurrent sedative or opioid administration 1
  • Patients with cardiovascular instability are at high risk for benzodiazepine-induced systemic hypotension, especially when lorazepam is administered with other cardiopulmonary depressants 1, 2, 3
  • Hemodynamically unstable patients should avoid loading doses entirely 3
  • All benzodiazepines are metabolized by the liver, and lorazepam clearance is significantly reduced in patients with hepatic dysfunction 1, 2, 3
  • Delayed emergence from sedation occurs with hepatic impairment due to prolonged elimination half-life 1, 2
  • The elimination half-life and duration of clinical effect are increased in patients with renal failure 1, 2, 3
  • Prolonged effects occur with renal dysfunction, requiring dose adjustments 4
  • Elderly patients are significantly more sensitive to sedative effects of benzodiazepines 1, 2, 3, 4
  • Benzodiazepine clearance decreases with age 1, 2, 3
  • Benzodiazepines should be avoided in older patients with cognitive impairment due to documented decreased cognitive performance 5
  • Parenteral lorazepam contains propylene glycol, which can cause metabolic acidosis and acute kidney injury in ICU patients 1, 2, 3
  • Total daily IV doses as low as 1 mg/kg can cause propylene glycol toxicity (not just high-dose continuous infusions) 1, 2, 3
  • Monitor serum osmol gap: values >10-12 mOsm/L indicate significant propylene glycol accumulation 1, 2, 3

Common Clinical Pitfalls

  • Paradoxical agitation occurs in approximately 10% of patients treated with benzodiazepines 4
  • Tolerance develops with long-term administration, requiring higher doses to achieve the same effect 1, 4
  • Cognitive impairment is associated with long-term use 4

Drug Interaction Cautions

  • Avoid concurrent use with other medications that inhibit cytochrome P450 enzyme systems or glucuronide conjugation, as this reduces benzodiazepine clearance 1, 2, 3
  • Extreme caution with opioid co-administration due to synergistic respiratory depression and hypotension 1, 2, 3

Contraindications and Precautions for Lorazepam Use

Critical Clinical Situations Requiring Extreme Caution

  • Baseline respiratory insufficiency significantly increases risk of benzodiazepine-induced respiratory depression, particularly when lorazepam is combined with opioids or other CNS depressants, in patients with severe pulmonary insufficiency 6, 7, 8
  • All benzodiazepines are metabolized by the liver, and lorazepam clearance is significantly reduced in patients with hepatic dysfunction, requiring cautious use in severe liver disease 6, 7, 8
  • Benzodiazepines should be avoided in patients with myasthenia gravis, unless using in imminently dying patient 6, 7, 8
  • Use lower doses (0.25–0.5 mg) in patients with COPD or when co-administered with antipsychotics, and in older or frail patients 6, 7, 8

Dangerous Drug Interactions

  • Fatalities have been reported with concurrent use of benzodiazepines with high-dose olanzapine, and risk of oversedation and respiratory depression when combining with benzodiazepines 6, 7, 8
  • Lorazepam may cause delirium, drowsiness, and paradoxical agitation, and increased risk of falls in all patients, particularly elderly 6, 7, 8